| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3998 | Para-nitroblebbistatin | Selective cell-permeable inhibitor of non-muscle myosin II ATPases, being more stable and less phototoxic than Blebbistatin |
|
| DCC3999 | Paraoxon | Acetylcholinesterase inhibitor, the active metabolite of the insecticide parathion |
|
| DCC4000 | Paraquat Diiodide | Non-selective contact herbicide, killing green plant tissue on contact, being highly toxic and linked to Parkinson's disease, generating reactive oxygen species (ROS), which causes cell death and potentially leading to acute respiratory distress syndrome |
|
| DCC4001 | Parogrelil | Novel potent phosphodiesterase 3 inhibitor, suppressing the asthmatic response and showing both bronchodilating and anti-inflammatory effects |
|
| DCC4002 | Parogrelil Hydrochloride | Novel potent phosphodiesterase 3 inhibitor, suppressing the asthmatic response and showing both bronchodilating and anti-inflammatory effects |
|
| DCC4003 | Parp/brd4 Inhibitor Iii-16 | Potent and Novel Dual PARP/BRD4 Inhibitor for Efficient Treatment of Pancreatic Cancer |
|
| DCC4004 | Parp1/brd4 Inhibitor Iii-7 | Novel highly selective dual PARP1/BRD4 inhibitor (PARP1 IC 50 =49nM; BRD4 IC 50 =202nM), repressing the expression and activity of PARP1 and BRD4 to synergistically inhibit the malignant growth of pancreatic cancer cells in vitro and in vivo |
|
| DCC4005 | Parp10-in-22 | Novel Selective Cell-Active Inhibitor of PARP10 |
|
| DCC4006 | Parpi-fl | Fluorescent PARP1 Inhibitor for Glioblastoma Imaging |
|
| DCC4007 | Parvifoline Aa | Natural ent-kaurane diterpenoid, markedly stimulates the expression of NKG2D ligands on hepatocellular carcinoma (HCC) cells, considerably enhancing their recognition and lysis by NK cells, covalently inhibiting peroxiredoxins I/II (Prxs-I/II) catalytic a |
|
| DCC4008 | Pav-866 | Novel antiviral agent, potently against Rabies virus (RABV) targeting host-rabies virus protein-protein interactions |
|
| DCC4009 | Pazinaclone | Partial agonist at GABAA benzodiazepine receptors with sedative and anxiolytic effects |
|
| DCC4010 | pbdnj0802 | Novel potent inhibitor of |
|
| DCC4011 | pbdnj0804 | Novel potent glucosidase inhibitor, suppressing HCV virion assembly and secretion, potently inhibiting DENV infection in vitro |
|
| DCC4012 | Pbi.105 | Novel Inhibitor of Parasite Proliferation of Asexual Blood Stage P. falciparum Parasites |
|
| DCC4013 | Pbi.120 | Novel Inhibitor of Parasite Proliferation of Asexual Blood Stage P. falciparum Parasites |
|
| DCC4014 | Pbi-1393 | Novel enhancer of Th1 type cytokine production and primary T cell activation |
|
| DCC4015 | Pbiilh2 | Pyridobenzimidazole infraluciferin, an analog of D-luciferin, increasing bioluminescence activity while maintaining nIR bioluminescence |
|
| DCC4016 | P-bi-tat | Novel αvβ3 inhibitor, showing excellent efficacy in a glioblastoma multiforme (GBM) mouse model |
|
| DCC4017 | Pbs-1086 | Novel dual inhibitor of the canonical and noncanonical NF-κB pathways, increasing the magnitude and duration of initial EGFR inhibitor response in multiple NSCLC models, decreasing PDHK1 expression, and suppressing phosphorylation of the PDHK1 protein sub |
|
| DCC4018 | Pb-wut-01 | Novel calcineurin inhibitor in the C. albicans cells, enhancing susceptibility of the cells |
|
| DCC4019 | pc-046 | Potent tubulin-binding agent with anti-tumor efficacy in hematologic cancers |
|
| DCC4020 | Pc407-ws | Water-soluble novel potential COX-2 inhibitor |
|
| DCC4021 | Pcb153 | Non-dioxin-like (NDL) congener |
|
| DCC4022 | Pcb-te2p | Novel Chelator for Cu-64 |
|
| DCC4023 | Pcc-0105002 | Novel PSD95-nNOS inhibitor, disrupting the PSD95-nNOS interaction, attenuating neuropathic pain, decreasing SNL-induced spinal dorsal horn WDR neuron hyperexcitation |
|
| DCC4024 | Pcc0208018 | Novel activator of effector T cells, enhancing T cell proliferation and activation to release interferon gamma (IFN-γ) and interleukin-2 (IL-2) without blocking the programmed cell death 1 (PD-1)/programmed cell death-ligand 1 (PD-L1) binding and not dire |
|
| DCC4025 | P-cf3-diepp | Novel α7 nAChR weak partial agonist, showing antinociceptive and anti-inflammatory properties |
|
| DCC4026 | p-chloro-diphenyl Diselenide | Organoselenium compound with antidepressant-like and memory enhancer actions |
|
| DCC4027 | pcm126 | Potent antagonist of the series disrupting EphA2-ephrinA1 interaction, blocking EphA2 phosphorylation in prostate cancer cells at low |
|
